Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / I••• B•••••••• •

K•••••••• C•••••• acquires majority stake in Isto B••••••••, a leading orthobiologics player, from T••••••• S••••• Capital Partners

Exit to a strategic buyerannouncedannounced Sep 17, 2025Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
industrials / manufactur
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • K•••••••• C•••••• (“K••••••••”), one of the leading private equity managers dedicated to pan-European Growth Buyout 1 investments, today announced it has agreed to acquire a majority stake in Isto B•••••••• from T••••••• S••••• Capital Partners (“TSCP”).
Sell side
Advisory side
  • P••••••••• P•Legal adviserconfirmed
    DC advisors acted as the financial advisor and P••••••••• acted as the legal advisor to Isto and TSCP.
Side not stated
  • Don Brown, CEO, and B•••• B•••••, President of Isto B••••••••, said: “Building on our successful collaboration with TSCP, we are looking forward to working with K•••••••• as we enter the next phase of our growth.
  • Amit Karna and D•••• P••••••, Partners at K•••••••• C••••••, added: “We have been investors in the biomaterials, orthopedics, spine and bone repair segments for over 20 years, and have been tracking Isto B•••••••• specifically for more than 5 years.
  • K•••••••• C•••••• (“K••••••••”), one of the leading private equity managers dedicated to pan-European Growth Buyout 1 investments, today announced it has agreed to acquire a majority stake in Isto B•••••••• from T••••••• S••••• Capital Partners (“TSCP”).
Evidence
K•••••••• C•••••• (“K••••••••”), one of the leading private equity managers dedicated to pan-European Growth Buyout 1 investments, today announced it has agreed to acquire a majority stake in Isto B•••••••• from T••••••• S••••• Capital Partners (“TSCP”).